204 related articles for article (PubMed ID: 25940761)
1. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
Tsui T; Miller WT
Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
[TBL] [Abstract][Full Text] [Related]
2. Role of the Brk SH3 domain in substrate recognition.
Qiu H; Miller WT
Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
4. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
Castro NE; Lange CA
Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
[TBL] [Abstract][Full Text] [Related]
5. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
Lukong KE; Huot ME; Richard S
Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
[TBL] [Abstract][Full Text] [Related]
6. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
[TBL] [Abstract][Full Text] [Related]
7. Tracing the footprints of the breast cancer oncogene BRK - Past till present.
Goel RK; Lukong KE
Biochim Biophys Acta; 2015 Aug; 1856(1):39-54. PubMed ID: 25999240
[TBL] [Abstract][Full Text] [Related]
8. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
9. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
[TBL] [Abstract][Full Text] [Related]
10. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
11. HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain.
Ai M; Qiu S; Lu Y; Fan Z
Cell Signal; 2013 Sep; 25(9):1754-61. PubMed ID: 23707532
[TBL] [Abstract][Full Text] [Related]
12. Brk/PTK6 signaling in normal and cancer cell models.
Ostrander JH; Daniel AR; Lange CA
Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360
[TBL] [Abstract][Full Text] [Related]
13. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration.
Lukong KE; Richard S
Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133
[TBL] [Abstract][Full Text] [Related]
14. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
Qiu H; Miller WT
J Biol Chem; 2002 Sep; 277(37):34634-41. PubMed ID: 12121988
[TBL] [Abstract][Full Text] [Related]
16. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
[TBL] [Abstract][Full Text] [Related]
17. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.
Kim HIe; Jung J; Lee ES; Kim YC; Lee W; Lee ST
Biochem Biophys Res Commun; 2007 Nov; 362(4):829-34. PubMed ID: 17822667
[TBL] [Abstract][Full Text] [Related]
19. Interaction between Brk kinase and insulin receptor substrate-4.
Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
[TBL] [Abstract][Full Text] [Related]
20. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
Ai M; Liang K; Lu Y; Qiu S; Fan Z
Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
